Publication

Published papers

Akt1 decreases Gcn5 protein stability through regulating the ubiquitin-proteasome pathway in mouse embryonic fibroblasts.

Jeong DS, Kim YC, Oh JH^†, and Kim MH^†
Cell Journal. 2022

HOXB5 confers tamoxifen resistance in breast cancer cells and promotes tumor aggression and progression.

Kim CY, Kim YC, Oh JH^†, and Kim MH^†
Anticancer Research. 2021

NR4A1 regulates tamoxifen resistance by suppressing ERK signaling in ER-positive breast cancer.

Kim CY, Kim YC, Oh JH^†, and Kim MH^†
Cells, 2021

HOXA5 confers tamoxifen resistance via the PI3K/AKT signaling pathway in ER-positive breast cancer

Kim CY, Kim YC, Oh JH^†, and Kim MH^†
Journal of Cancer. 2021

Elevated GCN5 expression confers tamoxifen resistance by upregulating AIB1 expression in ER-positive breast cancer.

Oh JH, Lee J-Y, Kim KH, Kim CY, Jeong DS, Cho Y, Nam KT^†, and Kim MH^†
Cancer Letters. 2020

The LncRNA HOTAIRM1 promotes tamoxifen resistance by mediating HOXA1 expression in ER+ breast cancer cells.

Kim CY, Oh JH, Lee J-Y^†, and Kim MH^†
Journal of Cancer. 2020